[ad_1]
Sandra Fraihofer, a spokeswoman for the American Medical Association, said the two new vaccines, Pfizer and Moderna, should be injected at two intervals.
The doctor indicates that he is concerned that patients may not participate in the second vaccination because they may have experienced the unpleasant side effects of the vaccine after the first injection.
“We really need to inform patients that the vaccine won’t be a walk in the park.
They will know they have been vaccinated. They are unlikely to feel very well, but they will have to come for a revaccination, ”Fraihofer said.
The Apollo portal has already reported that during vaccine trials in September, volunteers reported fever, muscle aches, severe headaches, all-day fatigue, and other symptoms that appeared after the injection.
Although these symptoms were very unpleasant and sometimes very severe, patients reported that they usually disappeared after a few days or even earlier.
Both companies developing the vaccine have also acknowledged that vaccines could have unpleasant side effects similar to moderate Covid-19 symptoms, such as body aches, fever and headache.
A 50-year-old resident of North Carolina who tested Moderna’s vaccine reported that she didn’t have a fever after the injection, but suffered from a severe migraine that deprived her of her strength and ability to concentrate all day.
He said he woke up more lively the next day, the court acknowledged that the company should inform people about the possibility of such side effects.
“If the vaccine proves effective, people will have to be strong and patient. The first dose is nothing special, but the second dose will definitely put people to bed for a few days,” he said.
However, the researchers also reported that some people in the vaccine studies were disappointed that they did not experience the same side effects as others, thinking they were injected with placebo.
It has already been reported that on November 9 Pfizer and BioNTech announced that their experimental vaccine, with a 90% effectiveness, could prevent the development of Covid-19 symptoms. This is an extremely high result for the first generation vaccine. Many did not even dream that its efficiency could exceed 70%.
.
[ad_2]
Source link
